Physician
Rabinowitz, Marvin
Rabinowitz, Marvin was paid $164K by Medicaid between Jan 2018 and Dec 2023, across 5 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 54% of everything it billed.
33Billing provider infoRABINOWITZ, MARVIN
HERKIMER, NY 13350
HERKIMER, NY 13350
33aNPI1164462206assigned 06/07/2006
33bProvider typeInfectious Disease Physician
28Total paid$164K
24GClaims3,695
24DCodes billed5
24AFirst – last monthJan 2018 – Dec 2023
Compared with peers
Next to other Infectious Disease Physician providers in New York
Rank by total paid#26 of 333
Median peer was paid$7K
This provider vs. median24×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,207 | $56K | |
| 2019 | 1,148 | $47K | |
| 2020 | 654 | $27K | |
| 2021 | 326 | $15K | |
| 2022 | 201 | $11K | |
| 2023 | 159 | $8K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 54% | 1,295 | 1,008 | $88K |
| 99442 | 28% | 1,014 | 910 | $46K | |
| 80305 | 9.1% | 1,188 | 1,005 | $15K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 8.3% | 137 | 122 | $14K |
| 90658 | <1% | 61 | 59 | $1K |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.